Integra LifeSciences of Plainsboro, New Jersey is releasing its new CUSA Clarity, an ultrasonic ablation system intended for neurosurgical applications that is both FDA and CE Mark cleared. The device offers some improvements over the company’s CUSA Excel+ system, particularly offering a considerably faster rate of tissue ablation, including approximately 50% faster removal of fibrous tissue.
The CUSA Clarity features adaptive power delivery, a tough tissue tip, and delivers continuous contact with target tissue. Integra is also touting the ergonomics of the handpiece, which it claims will offer more precision while reducing strain during long procedures, as well as the touchscreen display, and quick connect cartridge and tubing set.
“This latest innovation in tissue ablation is a result of Integra’s focus on designing and developing an advanced system that meets the surgeons’ needs for enhanced surgical performance, especially for longer and tougher cases like fibrous tissue removal,” said Dan Reuvers, president of the Specialty Surgical Solutions division for Integra, in a statement. “We’re delighted to bring this new system to a demanding surgical environment that enhances patient care.”
Product page: CUSA Clarity…
Via: Integra…
